Should you buy Ramsay Health Care and 2 other healthcare shares?

Should you buy Ramsay Health Care Limited (ASX:RHC) shares and two others in the healthcare sector?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're a fan of buy and hold investing then I think the healthcare sector is a great place to look for investment ideas.

This is because due to ageing populations, increased chronic disease burden, and better technologies, I expect demand for healthcare services to increase significantly over the next decade or two.

With that in mind, should you buy these healthcare shares?

Nanosonics Ltd (ASX: NAN)

Nanosonics is an infection control specialist which I believe has a bright future ahead of it. At present the company is a bit of one-trick pony with its hugely popular trophon EPR product, which provides high-level disinfection of ultrasound probes. But management is intent on releasing a range of new products over the coming years. The first of which is expected to be released by the end of FY 2020. I believe these new products and the sizeable market opportunity for trophon EPR will lead to above-average earnings growth over the next decade. This could make it a great buy and hold option.

Ramsay Health Care Limited (ASX: RHC)

While I think that Ramsay Health Care is one of the highest quality companies on the Australian share market, I wouldn't be a buyer of its shares at present. This is because the company's operations in Australia, France, and the UK are all facing tough trading conditions currently and I don't believe things are going to improve quickly. In light of this, I think the private hospital operator could continue to underwhelm over the next couple of years.

Volpara Health Technologies Ltd (ASX: VHT)

I think that Volpara is one of the best healthcare shares at the small end of the market. The New Zealand-based medical technology company provides software that uses AI imaging algorithms to assist in the early detection of breast cancer. The company has been growing its share of the U.S. breast screening market at a quick pace, which has led to strong growth in annual recurring revenue (ARR). As of its last update, Volpara's ARR had grown 56% since the end of FY 2018. Due to the quality of its product, I believe there is still a significant runway of growth ahead of the company, which could make it worth considering a small investment in its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and VOLPARA FPO NZ. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »